| Category | Finding | Details | Key experimental evidence | Citations |
|---|---|---|---|---|
| Primary molecular function/activity | Trafficking adaptor/regulator, not an enzyme | LZTFL1 functions as a regulatory trafficking protein rather than a catalyst; current evidence supports roles in ciliary/BBSome trafficking and clathrin adaptor-mediated membrane trafficking | Reviews place LZTFL1/BBS17 among BBSome regulators; primary studies show direct protein-protein interactions and trafficking phenotypes rather than enzymatic activity (pqac-00000004, pqac-00000005, pqac-00000012) | (pqac-00000004, pqac-00000005, pqac-00000012) |
| Primary molecular function/activity | Negative regulator of BBSome ciliary entry / regulator of BBSome export dynamics | LZTFL1 regulates BBSome behavior in cilia and is required for proper coupling of BBSome-dependent export with IFT machinery | Reviews summarize that LZTFL1 loss causes BBSome accumulation in cilia; RABL2(Q80L) or IFT27 defects phenocopy abnormal ciliary accumulation of LZTFL1/BBSome and impaired GPCR export (pqac-00000004, pqac-00000006, pqac-00000008) | (pqac-00000004, pqac-00000006, pqac-00000008) |
| Primary molecular function/activity | Accessory factor for AP-1/AP-2-mediated trafficking | LZTFL1 directly binds adaptor complexes AP-1 and AP-2 and helps regulate specific cargo trafficking, especially transferrin receptor 1 (TfR1) | In vitro pull-down and co-immunoprecipitation showed direct binding to AP-1/AP-2 and functional effects on TfR1 surface levels and endocytosis (pqac-00000002, pqac-00000003, pqac-00000012, pqac-00000017) | (pqac-00000002, pqac-00000003, pqac-00000012, pqac-00000017) |
| Direct binding partners | IFT27 | LZTFL1 physically associates with IFT27, linking it functionally to the IFT-B/BBSome axis | Identified by yeast two-hybrid; confirmed by co-immunoprecipitation, colocalization, and luciferase complementation assays (pqac-00000014, pqac-00000016) | (pqac-00000014, pqac-00000016) |
| Direct binding partners | AP-1 β1 subunit | Direct binding to AP-1 β1 supports a role in AP-1-dependent membrane trafficking | Purified-protein pull-down assays demonstrated direct interaction with AP-1 β1 but not all AP-1 subunits (pqac-00000003, pqac-00000012) | (pqac-00000003, pqac-00000012) |
| Direct binding partners | AP-2 β2 subunit | Direct binding to AP-2 β2 suggests participation in endocytic adaptor pathways | Purified-protein pull-down assays showed direct interaction dependent on an AP-binding motif in LZTFL1 (pqac-00000003, pqac-00000012) | (pqac-00000003, pqac-00000012) |
| Direct binding partners | TfR1 is an indirect partner/cargo-associated protein | LZTFL1 co-immunoprecipitates with TfR1, but available evidence indicates the interaction is indirect, likely via AP-1/AP-2 complexes | Co-IP detected association, whereas purified-protein assays did not show direct LZTFL1-TfR1 binding; DxxFxxLxxxR motif was required for the association in cells (pqac-00000017, pqac-00000018) | (pqac-00000017, pqac-00000018) |
| Subcellular localization | Cytoplasm | LZTFL1 is predominantly cytoplasmic in transfected cells and endogenous contexts | CHO-cell localization showed cytoplasmic LZTFL1; review/primary literature describe it as a cytoplasmic and ciliary protein (pqac-00000002, pqac-00000016) | (pqac-00000002, pqac-00000016) |
| Subcellular localization | Perinuclear region / trans-Golgi network-associated compartment | LZTFL1 colocalizes with AP-1 in the perinuclear region encompassing TGN and peripheral endosomal compartments | Immunofluorescence, BFA washout, and AP-1 knockdown experiments showed Arf-dependent PNR localization and AP-1 dependence of PNR accumulation (pqac-00000018) | (pqac-00000018) |
| Subcellular localization | Primary cilium | LZTFL1 localizes to cilia and participates in ciliary protein trafficking and signaling organization | Cilia-focused reviews and IFT/BBSome studies place LZTFL1 within the ciliary trafficking system; ciliary accumulation occurs in trafficking-defective states (pqac-00000004, pqac-00000005, pqac-00000006, pqac-00000008) | (pqac-00000004, pqac-00000005, pqac-00000006, pqac-00000008) |
| Subcellular localization | Spermatid cytoplasm, developing flagellum, and manchette-proximal region | In germ cells, LZTFL1 shows a vesicular cytoplasmic pattern in round spermatids and later localizes to developing flagella and near the manchette | Testis immunofluorescence during spermiogenesis documented stage-specific localization (pqac-00000000, pqac-00000016) | (pqac-00000000, pqac-00000016) |
| Major biological pathways | Intraflagellar transport/BBSome pathway | LZTFL1 acts in the IFT-B/BBSome system that controls ciliary membrane protein trafficking, especially export/removal of selected cargos from cilia | Reviews and mechanistic studies connect LZTFL1 with IFT27/IFT25 and BBSome trafficking; defects cause BBSome/LZTFL1 accumulation and GPCR export failure (pqac-00000004, pqac-00000005, pqac-00000006) | (pqac-00000004, pqac-00000005, pqac-00000006) |
| Major biological pathways | Hedgehog signaling | Through its role in ciliary trafficking, LZTFL1 is linked to Hedgehog pathway organization, including trafficking of Smoothened/GPR161-related machinery and tip localization of signaling proteins | IFT27/BBSome pathway studies show defects in ciliary trafficking of Smo/GPR161 and Gli/Kif7/SuFu localization when this axis is perturbed (pqac-00000006, pqac-00000008) | (pqac-00000006, pqac-00000008) |
| Major biological pathways | Clathrin-mediated endocytosis and recycling | LZTFL1 contributes to AP-1/AP-2-dependent trafficking of TfR1, affecting transferrin uptake, efflux, and internalization | LZTFL1 knockout reduced TfR1 surface abundance and endocytosis/internalization kinetics without broadly affecting all AP-1 cargos tested (pqac-00000002, pqac-00000017, pqac-00000018) | (pqac-00000002, pqac-00000017, pqac-00000018) |
| Major biological pathways | Epithelial-mesenchymal transition (EMT) / epithelial differentiation | LZTFL1 is implicated as an EMT-suppressive factor in epithelial cells and cancer contexts; increased LZTFL1 expression is linked to reduced EMT, while suppression promotes invasion/metastasis | COVID-19 risk-locus work highlighted LZTFL1 as an EMT-regulating effector in pulmonary epithelium; breast-cancer study identified LZTFL1 as a miR-21 target whose loss promotes EMT and metastasis (pqac-00000001, pqac-00000007, pqac-00000010) | (pqac-00000001, pqac-00000007, pqac-00000010) |
| Major biological pathways | Immune synapse formation | Earlier work cited in primary trafficking study places LZTFL1 in immune synapse biology in activated T cells | Introductory synthesis in the AP-1/AP-2 paper cites immune synapse participation as an established function (pqac-00000002) | (pqac-00000002) |
| Key experimental evidence | Motif/domain requirement for adaptor binding | The DxxFxxLxxxR motif is essential for AP-1/AP-2 binding and for indirect association with TfR1 | Mutagenesis in cell-based and in vitro assays abolished AP-1/AP-2 interaction and disrupted TfR1-associated behavior (pqac-00000002, pqac-00000012, pqac-00000017) | (pqac-00000002, pqac-00000012, pqac-00000017) |
| Key experimental evidence | Trafficking specificity for TfR1 | LZTFL1 loss reduced TfR1 cell-surface abundance by roughly 40-50%, but did not similarly alter EGFR or CI-MPR in the same assay system | Surface biotinylation and uptake/internalization assays in WT versus LZTFL1-knockout HeLa cells (pqac-00000017) | (pqac-00000017) |
| Key experimental evidence | Reproductive/ciliopathy phenotype in vivo | Lztfl1 deficiency causes reduced male fertility, low sperm motility, abnormal sperm morphology, and is linked to BBS phenotypes such as obesity and retinal degeneration | Knockout mouse analyses plus human BBS genetics support a physiological role in cilia/flagella biology (pqac-00000000, pqac-00000013, pqac-00000014) | (pqac-00000000, pqac-00000013, pqac-00000014) |
| Key experimental evidence | Human disease genetics and recent clinical relevance | Homozygous loss-of-function variants cause Bardet-Biedl syndrome (BBS17/LZTFL1); regulatory upregulation of LZTFL1 at 3p21.31 is implicated in severe COVID-19 risk in pulmonary epithelial cells | Recent consensus/review literature recognizes BBS17/LZTFL1; multi-omics fine-mapping identified LZTFL1 as the likely effector gene at the COVID-19 risk locus (pqac-00000001, pqac-00000010, pqac-00000013) | (pqac-00000001, pqac-00000010, pqac-00000013) |


*Table: This table summarizes the main experimentally supported functions, binding partners, localization, pathways, and disease-relevant evidence for human LZTFL1. It is useful as a compact evidence map linking molecular mechanism to cell biology and phenotype.*